Onconova Therapeutics Inc. / TESARO Inc. / Biopharmaceuticals Inc. / AbbVie Inc. / Designation Date Designation Contact Company / Contact Company/Sponsor Microbiotix Inc. / QLT Inc. / Lumena Pharmaceuticals Inc. / Atterocor Inc. / Ferrokin BioSciences Inc. / 273 Onconova Therapeutics Inc. / Zalicus Pharmaceuticals Ltd. / Catalyst Pharmaceutical Partners / Cyclacel Limited / Name Designation Date Designation Contact Company / CytRx Corporation / Mundipharma Research Limited / Murigenetics SAS Meritage Pharma Inc. / GlycoMimetics Inc. / Contact Company/Sponsor NATCO Pharma Limited Global / 273 Mundipharma Research Limited / 273 Eisai Inc. / Fujisawa / NephRx Corporation / ViroDefense Inc. / Novartis Pharmaceuticals / Pharmaceuticals' Inc. / Name Trade Name Designation Date Designation Contact Company / Trade Name Designation Date Designation Contact Company / AS NephRx Corporation / Otsuka Pharmaceutical Company Ltd / A2 Pharma / Astex Therapeutics Ltd / Teva / Generic Name Trade Name Contact Company / Research Ltd. / Infinity Pharmaceuticals Inc. / transplantation Inc. / Albireo AB / Auris Medical Inc. / NATCO Pharma Limited / Phase 2 Discovery Inc. / Fragile X syndrome Corp. / 273 AbbVie Inc / DARA BioSciences Inc. / Discoveries Inc. / 273 Convergence Pharmaceuticals Ltd. / /
Facility
University Medical / terminal UkUnhibitor / /
IndustryTerm
Treatment of pancreatic cancer / Treatment of Fragile X syndrome / Treatment of ovarian cancer / 4/2012 syndrome Prevention / cancer Treatment / Treatment of alagille syndrome / Treatment of chronic lymphocytic leukemia / Treatment of circadian rhythm sleep disorders / Treatment of Fabry's disease / /
Center Foundation / Company/Sponsor NATCO Pharma Limited Global Alliance for TB Drug Development Pfizer Global Research and Development Treatment / / /
Product
fluorouracil / nitro / /
Technology
radiation / API / chemotherapy / Drug Development / /